Ontex Group N.v. · EURONEXT:ONTEX

Ontex — Ontex Group Nv Ord — Q2 2025 Earnings Presentation

14 slides from Ontex's earnings presentation, Jul 31, 2025

  1. Slide 1: H1 2025 results

    H1 2025 results July 16, 2025

  2. Slide 2: Disclaimer

    Disclaimer Forward-looking statements This presentation may include forward-looking statements. Forward-looking statements are statements regarding or based upon our management’s current intentions, beliefs or expectations relating to, among other things, Ontex’s future results of operations, financ

  3. Slide 3: Lower-than-expected volumes in H1 impacted profitability and cash generation

    Lower-than-expected volumes in H1 impacted profitability and cash generation H1 2025 Adj. EBITDA Revenue Leverage margin €880M 9.8% €(40)M 2.7x -4.0% LFL YOY -2.2pp YOY vs €43M in H1 24 vs 2.5x at 12/24 3

  4. Slide 4: Soft customer demand in baby care led to lower revenue

    Soft customer demand in baby care led to lower revenue H1 revenue YOY > Negative sales price carry-over from 2024 actions (in €M) 916 -9 -30 > Baby care down 10% LFL, reflecting lower customer demand  Retailer brand market demand down by high single digit in Europe Sales +9 879 +1 880 price -6 and

  5. Slide 5: Revenue decline explains the lower adj. EBITDA

    Revenue decline explains the lower adj. EBITDA Cost transformation program almost fully mitigates cost increases H1 adj. EBITDA YOY > Direct impact of price carry-over (in €M) +34 -19 > Volume/mix reduction leading to a significant relative impact on EBITDA incl. lower fixed cost absorption 110 -9 -

  6. Slide 6: Customer demand deteriorated further in Q2, magnified by temporary increases in raw material and operating costs

    Customer demand deteriorated further in Q2, magnified by temporary increases in raw material and operating costs Q1 & Q2 adj. EBITDA YOY (in €M) +34 -19 > Market environment deteriorated in Q2 110 -9 +19 -16  Customer demand deteriorated further, magnified by some -2 -22 customer destocking and sup

  7. Slide 7: Negative FCF with lower EBITDA and continued transformation

    Negative FCF with lower EBITDA and continued transformation Compensated by divestment proceeds 2025 H1 cash impact on net debt (in €M) > €(45)M capex at ~5% of Core 93 -8 revenue, temporarily higher -13 due to cost transformation and WC changes -10 business growth program & social liabilities -45 +1

  8. Slide 8: Leverage maintained below 3x

    Leverage maintained below 3x Net debt evolution (in €M) 146 (698) -40 +101 (612) -11 +10 (552) Other > Net debt reduced from €(612)M to €(552)M FCF M&A net Share Other [1] Cash proceeds buy-back > Leverage increased slightly to 2.7x due to lower LTM EBITDA, remains comfortably below 3.5x covenant [2

  9. Slide 9: Adverse events impacting H1 to ease in H2

    Adverse events impacting H1 to ease in H2 Adverse events in H1 Anticipated to improve in H2 Stable pricing expected sequentially, Negative pricing carry-over no further YOY impact Weaker demand in Europe & NA, especially for New contracts starting, in North America and Europe retailer brands, with l

  10. Slide 10: H2 adj. EBITDA expected to benefit both from volume growth and net cost improvement

    H2 adj. EBITDA expected to benefit both from volume growth and net cost improvement > Sales price expected largely stable 2025 H1 to H2 adj. EBITDA bridge (in €M) > Volume-driven revenue growth of 5-9% LFL, positively 114 - 124 impacting adj. EBITDA, and boosted by fixed cost absorption effect Opera

  11. Slide 11: Full year outlook adjusted post H1

    Full year outlook adjusted post H1 Free Revenue Adj. EBITDA Leverage cash flow down LFL by €200 - 210M ~€0M ~2.5X low single digit vs +3% - +5% LFL vs €232 - 238M vs remaining strong vs <2.5x previously previously previously previously H1 H2 H1 H2 H1 H2 06/25 12/25 -4% -2% - +2% €86M €114 - 124M €(4

  12. Slide 12: Confirming our strategy as we build solid foundations for the future

    Confirming our strategy as we build solid foundations for the future Structural improvement journey Completion status (July 2025) Healthier balance sheet 100% > Refinancing completed in H1 2025 Importance to > Divestments from Emerging Markets keep executing our strategy to Robust innovation pipelin

  13. Slide 13: Q&A

    Q&A 13

  14. Slide 14: Ontex— Here for you.

    Ontex— Here for you.

Ontex Group Nv Ord — Q2 2025 Earnings Presentation on 6ix